Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 531-538

  Do Thi, Thuy ^a   López, Elena ^a   Rodríguez Rojas, Alexandro ^a   Rodríguez Beltrán, Jerónimo ^a   Couce, Alejandro ^a   Guelfo, Javier R ^a   Castañeda García, Alfredo ^a   Blázquez, Jesús ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Antibiotic resistance; Mutations; Sulfamethoxazole; Trimethoprim

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; RIFAMPICIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; ESCHERICHIA COLI; GENE INACTIVATION; MINIMUM INHIBITORY CONCENTRATION; MUTAGENICITY; NONHUMAN; RECA GENE;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; GENE DELETION; HUMANS; MUTAGENESIS; MUTAGENS; MUTATION; REC A RECOMBINASES;

EID: 79951520139     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq496     Document Type: Article

References (53)

1. Perez-Capilla T, Baquero MR, Gomez-Gomez JM et al. SOS-independent induction of dinB transcription by b-lactam-mediated inhibition of cell wall Maranesis in Escherichia coli. J Bacteriol 2005; 187: 1515-8.
2. Ysern P, Clerch B, Castano M et al. Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. Mutagenesis 1990; 5: 63-6.
3. Kohanski MA, Depristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 2010; 37: 311-20.
4. Blazquez J, Gomez-Gomez JM, Oliver A et al. PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. Mol Microbiol 2006; 62: 84-99.
5. Lopez E, Blazquez J. Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli. Antimicrob Agents Chemother 2009; 53: 3411-5.
6. Lopez E, Elez M, Matic I et al. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli. Mol Microbiol 2007; 64: 83-93.
7. Kohanski MA, Dwyer DJ, Hayete B et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797-810.
8. Cirz RT, Chin JK, Andes DR et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biology 2005; 3: e176.
9. Cirz RT, Romesberg FE. Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob Agents Chemother 2006; 50: 220-5.
10. Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis 2003; 37: 1201-9.
11. Dwyer DJ, Kohanski MA, Collins JJ. Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol 2009; 12: 482-9.
12. Cirz RT, Gingles N, Romesberg FE. Side effects may include evolution. Nat Med 2006; 12: 890-1.
13. Lee AM, Ross CT, Zeng BB et al. A molecular target for suppression of the evolution of antibiotic resistance: inhibition of the Escherichia coli RecA protein by N(6)-(1-naphthyl)-ADP. J Med Chem 2005; 48: 5408-11.
14. Little JW, Edmiston SH, Pacelli LZ et al. Cleavage of the Escherichia coli LexA protein by the RecA protease. Proc Natl Acad Sci USA 1980; 77: 3225-9.
15. Luo Y, Pfuetzner RA, Mosimann S et al. Crystal structure of LexA: a conformational switch for regulation of self-cleavage. Cell 2001; 106: 585-94.
16. Camas FM, Blazquez J, Poyatos JF. Autogenous and nonautogenous control of response in a genetic network. Proc Natl Acad Sci USA 2006; 103: 12718-23.
17. Courcelle J, Hanawalt PC. RecA-dependent recovery of arrested DNA replication forks. Annu Rev Genet 2003; 37: 611-46.
18. Lusetti SL, Cox MM. The bacterial RecA protein and the recombinational DNA repair of stalled replication forks. Annu Rev Biochem 2002; 71: 71-100.
19. Friedberg EC. Suffering in silence: the tolerance of DNA damage. Nat Rev Mol Cell Biol 2005; 6: 943-53.
20. Kowalczykowski SC, Dixon DA, Eggleston AK et al. Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev 1994; 58: 401-65.
21. Gomez-Gomez JM, Manfredi C, Alonso JC et al. A novel role for RecA under non-stress: promotion of swarming motility in Escherichia coli K-12. BMC Biol 2007; 5: 14.
22. Boles BR, Thoendel M, Singh PK. Self-generated diversity produces "insurance effects" in biofilm communities. Proc Natl Acad Sci USA 2004; 101: 16630-5.
23. Elez M, Radman M, Matic I. The frequency and structure of recombinant products is determined by the cellular level of MutL. Proc Natl Acad Sci USA 2007; 104: 8935-40.
24. Ronen M, Rosenberg R, Shraiman BI et al. Assigning numbers to the arrows: parameterizing a gene regulation network by using accurate expression kinetics. Proc Natl Acad Sci USA 2002; 99: 10555-60.
25. Miller JH. A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli Related Bacteria. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1992.
26. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2008.
27. Couce A, Blazquez J. Side effects of antibiotics on genetic variability. FEMS Microbiol Rev 2009; 33: 531-8.
28. Miller C, Thomsen LE, Gaggero C et al. SOS response induction by b-lactams and bacterial defense against antibiotic lethality. Science 2004; 305: 1629-31.
29. Gillespie SH, Basu S, Dickens AL et al. Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother 2005; 56: 344-8.
30. Lederberg J, Lederberg EM. Replica plating and indirect selection of bacterial mutants. J Bacteriol 1952; 63: 399-406.
31. Luria SE, Delbruck M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943; 28: 491-511.
32. Newcombe HB. Origin of bacterial variants. Nature 1949; 164: 150.
33. Mao EF, Lane L, Lee J et al. Proliferation of mutators in a cell population. J Bacteriol 1997; 179: 417-22.
34. Power EG, Phillips I. Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents. FEMS Microbiol Lett 1993; 112: 251-4.
35. Lewin CS, Howard BM, Ratcliffe NT et al. 4-quinolones and the SOS response. J Med Microbiol 1989; 29: 139-44.
36. Amyes SG, Smith JT. Trimethoprim action and its analogy with thymine starvation. Antimicrob Agents Chemother 1974; 5: 169-78.
37. Lewin CS, Amyes SG. The role of the SOS response in bacteria exposed to zidovudine or trimethoprim. J Med Microbiol 1991; 34: 329-32.
38. Peterson AR, Danenberg PV, Ibric LL et al. Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis. Basic Life Sci 1985; 31: 313-34.
39. Kunz BA, Kohalmi SE. Modulation of mutagenesis by deoxyribonucleotide levels. Annu Rev Genet 1991; 25: 339-59.
40. Huisman O, D'Ari R. An inducible DNA replication-cell division coupling mechanism in E. coli. Nature 1981; 290: 797-9.
41. Maguin E, Lutkenhaus J, D'Ari R. Reversibility of SOS-associated division inhibition in Escherichia coli. J Bacteriol 1986; 166: 733-8.
42. Kawarai T, Wachi M, Ogino H et al. SulA-independent filamentation of Escherichia coli during growth after release from high hydrostatic pressure treatment. Appl Microbiol Biotechnol 2004; 64: 255-62.
43. Morosini MI, Blazquez J, Negri MC et al. Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen. J Infect Dis 1996; 174: 1015-20.
44. Blazquez J, Morosini MI, Negri MC et al. Selection of naturally occurring extended-spectrum TEM b-lactamase variants by fluctuating b-lactam pressure. Antimicrob Agents Chemother 2000; 44: 2182-4.
45. Blazquez J, Morosini MI, Negri MC et al. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM b-lactamases. Antimicrob Agents Chemother 1995; 39: 145-9.
46. Morosini MI, Negri MC, Shoichet B et al. An extended-spectrum AmpC-type b-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol Lett 1998; 165: 85-90.
47. Piddock LJ. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 2006; 4: 629-36.
48. Denamur E, Tenaillon O, Deschamps C et al. Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli. Genetics 2005; 171: 825-7.
49. Andremont A. Commensal flora may play key role in spreading antibiotic resistance. ASM News 2003; 69: 601-7.
50. Cirz RT, Romesberg FE. Controlling mutation: intervening in evolution as a therapeutic strategy. Crit Rev Biochem Mol Biol 2007; 42: 341-54.
51. Wigle TJ, Singleton SF. Directed molecular screening for RecA ATPase inhibitors. Bioorg Med Chem Lett 2007; 17: 3249-53.
52. Cline DJ, Holt SL, Singleton SF. Inhibition of Escherichia coli RecA by rationally redesigned N-terminal helix. Org Biomol Chem 2007; 5: 1525-8.
53. Wigle TJ, Sexton JZ, Gromova AV et al. Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli. J Biomol Screen 2009; 14: 1092-101.